Samantha Ng1, Elaine M Pascoe2, David W Johnson1,2,3, Carmel M Hawley1,2,3, Kevan R Polkinghorne4,5,6, Stephen McDonald7, Philip A Clayton7, Kannaiyan S Rabindranath8, Matthew A Roberts7,9, Ashley B Irish10,11, Andrea K Viecelli1,2. 1. Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia. 2. Australasian Kidney Trials Network, Faculty of Medicine, University of Queensland, Brisbane, Australia. 3. Translational Research Institute, Brisbane, Australia. 4. Department of Nephrology, Monash Medical Center, Melbourne, Australia. 5. Department of Medicine, Monash University, Melbourne, Australia. 6. School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. 7. Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute, Adelaide, Australia. 8. Renal Unit, Waikato District Hospital, Hamilton, New Zealand. 9. Eastern Health Clinical School, Monash University, Melbourne, Australia. 10. Medical School, University of Western Australia, Perth, Australia. 11. Department of Nephrology, Fiona Stanley Hospital, Perth, Australia.
Abstract
Background: Commencing hemodialysis (HD) with an arteriovenous access is associated with superior patient outcomes compared with a catheter, but the majority of patients in Australia and New Zealand initiate HD with a central venous catheter. This study examined patient and center factors associated with arteriovenous fistula/graft access use at HD commencement. Methods: We included all adult patients starting chronic HD in Australia and New Zealand between 2004 and 2015. Access type at HD initiation was analyzed using logistic regression. Patient-level factors included sex, age, race, body mass index (BMI), smoking status, primary kidney disease, late nephrologist referral, comorbidities, and prior RRT. Center-level factors included size; transplant capability; home HD proportion; incident peritoneal dialysis (average number of patients commencing RRT with peritoneal dialysis per year); mean weekly HD hours; average blood flow; and achievement of phosphate, hemoglobin, and weekly Kt/V targets. The study included 27,123 patients from 61 centers. Results: Arteriovenous access use at HD commencement varied four-fold from 15% to 62% (median 39%) across centers. Incident arteriovenous access use was more likely in patients aged 51-72 years, males, and patients with a BMI of >25 kg/m2 and polycystic kidney disease; but use was less likely in patients with a BMI of <18.5 kg/m2, late nephrologist referral, diabetes mellitus, cardiovascular disease, chronic lung disease, and prior RRT. Starting HD with an arteriovenous access was less likely in centers with the highest proportion of home HD, and no center factor was associated with higher arteriovenous access use. Adjustment for center-level characteristics resulted in a 25% reduction in observed intercenter variability of arteriovenous access use at HD initiation compared with the model adjusted for only patient-level characteristics. Conclusions: This study identified several patient and center factors associated with incident HD access use, yet these factors did not fully explain the substantial variability in arteriovenous access use across centers.
Background: Commencing hemodialysis (HD) with an arteriovenous access is associated with superior patient outcomes compared with a catheter, but the majority of patients in Australia and New Zealand initiate HD with a central venous catheter. This study examined patient and center factors associated with arteriovenous fistula/graft access use at HD commencement. Methods: We included all adult patients starting chronic HD in Australia and New Zealand between 2004 and 2015. Access type at HD initiation was analyzed using logistic regression. Patient-level factors included sex, age, race, body mass index (BMI), smoking status, primary kidney disease, late nephrologist referral, comorbidities, and prior RRT. Center-level factors included size; transplant capability; home HD proportion; incident peritoneal dialysis (average number of patients commencing RRT with peritoneal dialysis per year); mean weekly HD hours; average blood flow; and achievement of phosphate, hemoglobin, and weekly Kt/V targets. The study included 27,123 patients from 61 centers. Results: Arteriovenous access use at HD commencement varied four-fold from 15% to 62% (median 39%) across centers. Incident arteriovenous access use was more likely in patients aged 51-72 years, males, and patients with a BMI of >25 kg/m2 and polycystic kidney disease; but use was less likely in patients with a BMI of <18.5 kg/m2, late nephrologist referral, diabetes mellitus, cardiovascular disease, chronic lung disease, and prior RRT. Starting HD with an arteriovenous access was less likely in centers with the highest proportion of home HD, and no center factor was associated with higher arteriovenous access use. Adjustment for center-level characteristics resulted in a 25% reduction in observed intercenter variability of arteriovenous access use at HD initiation compared with the model adjusted for only patient-level characteristics. Conclusions: This study identified several patient and center factors associated with incident HD access use, yet these factors did not fully explain the substantial variability in arteriovenous access use across centers.
Keywords:
arteriovenous access; arteriovenous fistula; center characteristics; center effect; center size; center variation; central venous catheter; dialysis; hemodialysis; vascular access
Authors: Braden Manns; Marcello Tonelli; Serdar Yilmaz; Helen Lee; Kevin Laupland; Scott Klarenbach; Val Radkevich; Brendan Murphy Journal: J Am Soc Nephrol Date: 2004-11-24 Impact factor: 10.121
Authors: Kenneth L Choi; Loay Salman; Gururaj Krishnamurthy; Carlos Mercado; Donna Merrill; Ian Thomas; Shukrat Artikov; Gabriel Contreras; Rao Ali Hashim Khan; Ali Warda; Arif Asif Journal: Semin Dial Date: 2008-06-28 Impact factor: 3.455
Authors: Ann M O'Hare; R Adams Dudley; Denise M Hynes; Charles E McCulloch; Daniel Navarro; Philip Colin; Kevin Stroupe; Joseph Rapp; Kirsten L Johansen Journal: Kidney Int Date: 2003-08 Impact factor: 10.612
Authors: Aminu K Bello; Ikechi G Okpechi; Mohamed A Osman; Yeoungjee Cho; Htay Htay; Vivekanand Jha; Marina Wainstein; David W Johnson Journal: Nat Rev Nephrol Date: 2022-02-22 Impact factor: 42.439